Advertisement
Advertisement
IDXX
Idexx Laboratories Inc
577.26
USDSponsored
-3.15
-0.54%
Mar 20, 15:59 UTC -4
Closed
Pre-Market
574.19
-3.07
-0.53%
IDXX Earnings Reports
Positive Surprise Ratio
IDXX beat 38 of 40 last estimates.
95%
Next Report
Date of Next Report
Apr 29, 2026
Estimate for Q1 26 (Revenue/ EPS)
$1.14B
/$3.47
Implied change from Q4 25 (Revenue/ EPS)
+4.69%
/+12.66%
Implied change from Q1 25 (Revenue/ EPS)
+14.35%
/+17.23%
Idexx Laboratories Inc earnings per share and revenue
On Feb 02, 2026, IDXX reported earnings of 3.08 USD per share (EPS) for Q4 25, beating the estimate of 2.98 USD, resulting in a 3.12% surprise. Revenue reached 1.09 billion, compared to an expected 1.09 billion, with a -0.32% difference. The market reacted with a -4.60% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 11 analysts forecast an EPS of 3.47 USD, with revenue projected to reach 1.14 billion USD, implying an increase of 12.66% EPS, and increase of 4.69% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Alpha Tau Medical Ltd. Ordinary Shares
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.12
Actual
-$0.08
Surprise
+36.51%
ClearPoint Neuro, Inc. Common Stock
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.20
Actual
-$0.27
Surprise
-32.35%
Stereotaxis, Inc. Common Stock
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.06
Surprise
+10.04%
Hyperfine, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.08
Surprise
+1.96%
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.22
Actual
-$0.28
Surprise
-23.35%
Neuronetics, Inc. Common Stock
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.10
Surprise
+8.09%
InspireMD, Inc.
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.14
Surprise
+29.01%
Tenon Medical, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.36
Actual
-$0.22
Surprise
+40.09%
Nuwellis, Inc. Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$1.59
Actual
-$1.50
Surprise
+5.73%
FAQ
What were Idexx Laboratories Inc's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Idexx Laboratories Inc reported EPS of $3.08, beating estimates by 3.12%, and revenue of $1.09B, -0.32% below expectations.
How did the market react to Idexx Laboratories Inc's Q4 2025 earnings?
The stock price moved down -4.6%, changed from $670.46 before the earnings release to $639.60 the day after.
When is Idexx Laboratories Inc expected to report next?
The next earning report is scheduled for Apr 29, 2026.
What are the forecasts for Idexx Laboratories Inc's next earnings report?
Based on 11
analysts, Idexx Laboratories Inc is expected to report EPS of $3.47 and revenue of $1.14B for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement